Bio-Techne

This weekend's Barron's cover story features the top picks from the 2019 Barron's Roundtable. Other featured articles offer bargain gold mining stocks and how to play the life sciences boom. Also, the prospects for office REITs, a retail stock on sale and a battleground stock. "...

Editor's Note: This is the second of a two-part series. Read Frank Mortari's comments on M&A possibilities. Bio-Techne (NASDAQ: TECH) has made two major acquisitions since June, spending $60 million to acquire Novus Biologicals and $300 million to pick up ProteinSimple. For a small...

Bio-Techne (NASDAQ: TECH) announced the $60 million acquisition of Novus Biologicals earlier this month and the $300 million acquisition of ProteinSimple in June.   In an exclusive interview with Benzinga, Director of Business Development Frank Mortari discussed M&A activity in the...